Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • News & Research

GLP-1 drugs show early signs of slowing biological ageing, but proof remains elusive

Preliminary analyses from Novo Nordisk, Eli Lilly and a University of California San Diego trial suggest popular diabetes and weight-loss medicines may affect biological-ageing markers, though they have not been shown to extend life. Early company-backed analyses suggest that widely…

  • apxadmin
  • October 15, 2026
  • Lifestyle & Wellbeing

Two short strength sessions a week could make blood sugar management more manageable

Short, repeatable resistance workouts can help muscles use glucose and improve insulin sensitivity, but people taking diabetes medication should plan exercise and glucose monitoring with their care team. Strength training can be a practical tool for people trying to manage…

  • apxadmin
  • October 15, 2026
  • Diet & Nutrition

Pearl barley’s overlooked fibre could help curb cholesterol and post-meal glucose spikes

Rich in beta-glucan, pearl barley may support heart health and steadier blood sugar after meals, although it is not a treatment for diabetes and is unsuitable for people with coeliac disease. Pearl barley is often overlooked as a side dish,…

  • apxadmin
  • October 15, 2026
  • Lifestyle & Wellbeing

Active brown fat linked to lower risk of heart disease, diabetes and depression

A study of more than 100,000 people found that measurable brown fat was associated with lower rates of serious metabolic, cardiovascular and psychiatric conditions, including among people who were overweight or obese. People with active brown fat appear to face…

  • apxadmin
  • October 15, 2026
  • Diet & Nutrition

Rezolute completes enrolment in pivotal trial for rare tumour-driven hypoglycaemia

The Phase III upLIFT study has enrolled all 16 planned participants with insulinoma or non-islet cell tumours, with topline results expected in mid-December 2026. Rezolute said it has finished enrolling patients in its Phase III upLIFT trial of ersodetug, a…

  • apxadmin
  • October 15, 2026
  • News & Research

GLP-1 drugs face fresh scrutiny over rare vision-loss warning

Evidence linking Ozempic, Wegovy and Mounjaro to a rare optic-nerve disorder remains limited, but regulators are urging urgent assessment after sudden vision changes. GLP-1 injections such as Ozempic, Wegovy and Mounjaro have transformed treatment for type 2 diabetes and obesity,…

  • apxadmin
  • October 15, 2026
  • News & Research

Binge eating symptoms linked to earlier type 2 diabetes diagnosis

A Danish study has found probable binge eating disorder in 2.9% of adults with type 2 diabetes, with symptoms associated with younger diagnosis, obesity, female sex and lower well-being. A new Danish study in Diabetic Medicine suggests binge eating symptoms…

  • apxadmin
  • October 15, 2026
  • News & Research

Immunocore takes ImmTAAI platform into type 1 diabetes with first patient dosed

The UK biotech has begun its first tissue-specific autoimmune trial, testing whether IMC-S118AI can protect insulin-producing beta cells while it expands beyond its KIMMTRAK-led cancer business. Immunocore said on 15 October, 2026, that it had dosed the first patient in…

  • apxadmin
  • October 15, 2026
  • Diet & Nutrition

Fenugreek leads spices’ mixed record on blood sugar control

Studies suggest fenugreek may modestly improve blood sugar markers, while evidence for cinnamon and ginger remains more mixed and supplements may interact with diabetes medicines. Fenugreek, cinnamon and ginger have long been used to flavour sweet and savoury dishes, but…

  • apxadmin
  • October 15, 2026
  • News & Research

InLife and The Medical City shift employee health cover towards earlier chronic disease intervention

The partnership will use health risk assessments, clinical care plans and ongoing monitoring to help employers detect and manage conditions such as hypertension and diabetes before they worsen. InLife Benefits and The Medical City have agreed to develop a chronic…

  • apxadmin
  • October 15, 2026
Prev
1 … 24 25 26 27 28 29 30 … 199
Next

Search

No results

Posts

Rebuilding muscle after uncontrolled diabetes: the importance of management and exercise

August 26, 2026

Midlife blood sugar management offers new hope for women’s weight loss and prediabetes reversal

September 20, 2026

Why cooling sweet potatoes could help steady blood sugar

October 21, 2026

Strawberries may be better than cherries for blood sugar control, but moderation remains key

September 22, 2026

Taiwanese expert highlights plain yoghurt's potential to support metabolic health

September 18, 2026

Trending now

FDA clears Novo Nordisk’s once-weekly insulin for children with type 2 diabetes
New guidelines help people with diabetes enjoy summer cookouts without guilt
Gestational diabetes alters early brain response to food cues during pregnancy
Personal glucose pattern analyser offers targeted insights for diabetes management

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy